IC43

· Valneva Austria GmbH

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IC43, covering 2012-10-19 to 2016-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 [Phase 2, Phase 3]